Zacks Research Has Negative Estimate for EW Q2 Earnings
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Analysts at Zacks Research reduced their Q2 2025 earnings per share estimates for Edwards Lifesciences in a report released on Tuesday, March 4th. Zacks Research analyst R. Department now expects that the medical research company will post earnings per share of $0.60 for the quarter, down from […]
